TABLE 2.
Patent drug name | Analytical Methods | Main chemical composition | References |
---|---|---|---|
Huaier granules | UHPLC-MS | Proteoglycan,1β-Hydroxyalantolactone, 2-Aminoisobutyric acid, 2-Hydroxybutanoic acid, 2-Isopropyl-3-oxosuccinate, 2′-O-Methyladenosine, 2-Picolinic acid, 3,4-Dihydroxyphenylacetaldehyde, 3-Ethyl-1,2-benzenediol | Pan et al. (2019), Jian et al. (2022) |
Ganfule granules | UPLC-Q-TOF-MS | Chlorogenic acid, amygdalin, 3′-deoxysappanone A, 10-O-Methylprotosappanin B, scutellarin, narirutin, hesperidin, hesperetin, nobiletin, 3,3′,4′,5,6,7,8-heptamethoxyflavone, saikosaponin A, Saikogenin C and astragaloside I | Xu et al. (2021) |
Fufang Banmao capsule | GC | Cantharidin, ginsenosides Rg1, ginsenosides Rb1, ginsenosides Re, astragaloside A, isofraxidin | Mi et al. (2003) |
Jinlong capsule | UPLC | Histidine, serine, arginine, glycine, aspartic acid, glutamate, threonine, alanine, proline, cystine, lysine, tyrosine, methionine, valine, isoleucine, leucine, phenylalanine | LI and Xiao, (2014) |
Brucea javanica oil emulsion | HPLC, GC-MS | Brusatol, bruceine D, bruceine H, yadanzioside A, yadanzioside G, javanicoside C and bruceantinoside A, phenol, hexadecanoic acid, octadecanoic acid, 9-Octadecenoic acid (oleic acid), 9E,12Z-Octadecadienoic acid (linoleic acid), 9Z,12Z,15Z-Octadecatrienoic acid | Chen et al. (2009), Zhang et al. (2011), Zhao et al. (2011), Tongtong Wang et al. (2021) |
Compound kushen injection | UPLC-MS, HPLC | Adenine, N-methylcytisine, sophorodine, matrine, sophocarpine, oxysophocarpine, oxymatrine, trifolirhizin | Qi et al. (2013), Gao et al. (2018), Shen et al. (2019) |
UPLC-MS, ultra-performance liquid chromatography/mass spectrometry; UPLC-Q-TOF-MS, ultra-performance liquid chromatography to quadrupole time-of-flight mass spectrometry; GC, gas chromatography; HPLC, liquid chromatography–mass spectrometry; GC-MS, gas chromatography-mass spectrometry; UHPLC-MS, ultrahigh-pressure liquid chromatography coupled with tandem mass spectrometry.